ID | 113405 |
タイトル別表記 | CRP in PMR and RS3PE syndrome
|
著者 |
河南, 真吾
The University of Tokushima
大倉, 佳宏
Tokushima University
湯浅, 志乃
Tokushima Prefectural Central Hospital
中西, 嘉憲
The University of Tokushima
川人, 圭祐
Yoshinogawa Medical Center
近藤, 啓介
Ehime Prefectural Central Hospital
Umetani, Kazumasa
Tokyo Bei Urayasu Ichikawa Medical Center
Miyatake, Akiko
Naruto Yamakami Hospital
鈴記, 好博
The University of Tokushima
|
キーワード | PMR
RS3PE syndrome
C-reactive protein
prednisolone
relapse
|
資料タイプ |
学術雑誌論文
|
抄録 | Polymyalgia rheumatica (PMR) and remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome are common inflammatory rheumatic diseases in the elderly. In this study, we investigate predictive factors which correspond to subsequent disease control of PMR and RS3PE syndrome. Twenty four patients, which contained 18 PMR and 6 RS3PE syndrome, were treated with initial dosages of 10-20 mg per day oral prednisolone, and the dosage of prednisolone was then tapered. Significantly higher initial CRP was observed in patients with poor disease control than in those with good disease control afterwards. The number of patients with negative CRP after 4 weeks was significantly more in patients with good disease control after 1 year than in those with poor disease control. Patients were shown to be in good disease control status after 1 year when CRP after 4 weeks became negative even if they had initial high CRP. Our study clarify that to make CRP negative after 4 weeks is associated with subsequent suppression of the disease activity and with decreased dosages of corticosteroids.
|
掲載誌名 |
The Journal of Medical Investigation
|
ISSN | 13496867
13431420
|
cat書誌ID | AA12022913
AA11166929
|
出版者 | Tokushima University Faculty of Medicine
|
巻 | 66
|
号 | 1-2
|
開始ページ | 112
|
終了ページ | 118
|
並び順 | 112
|
発行日 | 2019-02
|
EDB ID | |
出版社版DOI | |
出版社版URL | |
フルテキストファイル | |
言語 |
eng
|
著者版フラグ |
出版社版
|
部局 |
病院
医学系
|